| DATE |
SPEAKER |
TITLE |
| September 6 | Dhan Kuppuswamy, Ph.D. Associate Professor Medicine, Division of Cardiology |
Protein kinase signaling in hypertrophying myocardium. |
| September 13 |
Robin Muise-Helmericks, Ph.D. Assistant Professor Cell Biology and Anatomy Hollings Cancer Center |
The Akt family as downstream effectors of VEGF signaling. |
| September 20 | Dean Jones, Ph.D. Professor of Biochemistry Emory University |
Redefining oxidative stress in disease. |
| September 27 | Mike Wyatt, Ph.D. Associate Professor Biomedicinal Chemistry University of South Carolina |
Two aspects of base excision repair: damage recognition and influence on chemotherapy. |
| October 4 | Desuo Wang, Ph.D. Assistant Professor Pharmacology University of South Carolina |
Novel antihypertensive therapy: dually targeting type 4 phosphodiesterase (PDE4) and L-type calcium channels. |
| October 11 | Xuejun Wen, M.D., Ph.D. Assistant Professor MUSC-Clemson Bioengineering Program |
Tissue engineering for CNS repair. |
| October 18 | Gary Rankin,
Ph.D. Professor of Pharmacology Marshall University |
Biotransformation and succinimide-induced nephrotoxicity. |
| October 25 | David J. Kroll, Ph.D. Senior Research Pharmacologist Natural Products Laboratory |
Pure flavonolignans from milk thistle (Silybum marianum) as multiply-targeted chemopreventive and chemotherapeutic drugs. |
| November 1 | No seminar |
|
| November 8 | Amit Basu, Ph.D. Assistant Professor of Chemistry Brown University |
Glycosphingolipid interactions at membranes. |
| November 15 | No seminar |
|
| Wednesday November 30 |
William Zamboni, Pharm.D. Assistant Professor University of Pittsburgh Cancer Institute |
Preclinical and clinical development of liposomal and non-liposomal camptothecin analogues. |
| December 6 | Alice Villalobos, Ph.D. Assistant Professor Environmental Medicine University of Rochester |
Metal induced modulation of choline transport by choroid plexus. |
| December 13 |
Danyelle Townsend, Ph.D. Assistant Professor Pharmaceutical Sciences |
Preclinical development of chemotherapeutics that impact redox-balance. |